syngo.via MI WorkFlows, Scenium, syngo MBF

syngo.via MI WorkFlows VB60A is an advanced medical image processing software designed to enhance diagnostic capabilities by enabling comprehensive analysis, quantification, and visualization of multi-modality imaging data across neurology, cardiology, and oncology. The system employs specialized algorithms and enhanced workflows, including quantitative PET analysis for myocardial blood flow, neurological biomarker assessment with calibrated normal databases, and improved 4D data handling, to provide clinicians with detailed insights for disease management and treatment planning.

The syngo.via MI WorkFlows VB60A is a software-only medical device designed for advanced post-processing of medical images from multiple modalities, including Positron Emission Tomography (PET), Nuclear Medicine (NM), Computed Tomography (CT), and Magnetic Resonance (MR). Its primary purpose is to assist trained healthcare professionals in viewing, manipulating, quantifying, analyzing, and comparing these images to support diagnostic efforts and disease management across oncology, cardiology, neurology, and organ function assessment. The software, intended for installation on common IT hardware, integrates various workflows to present complex imaging data cohesively, enabling enhanced visualizations and offering features like Standardized Uptake Value (SUV) harmonization for PET data across different systems; its outputs can also aid in radiotherapy treatment planning. The system incorporates specialized modules like Scenium for neurological image analysis—assisting in the evaluation of conditions such as dementia, Parkinson's disease, and epilepsy through database comparisons, striatal, and cortical analysis—and syngo MBF for cardiology, which provides quantitative myocardial blood flow measurements from dynamic PET images using tracers like Rubidium and Ammonia. The VB60A version introduces several new features and enhancements, including updated syngo.CT LungCAD integration for oncology, visualization of 4D data, Gaussian filtering of PET data, interactive spectral imaging, an OpenApps framework for integrating cardiology applications, spill-over factor calculations and automatic window/leveling within syngo MBF, and new calibrated I123-FP-CIT normal databases for striatal analysis in Scenium. These tools utilize algorithms for image segmentation, quantification, and comparative analysis to furnish clinicians with detailed insights.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What are the specific validation metrics for the quantitative accuracy of myocardial blood flow measurements provided by syngo MBF, particularly concerning spill-over factor corrections and automatic window/leveling for each frame?; How does the 'Database Comparison' feature within Scenium, especially with the new calibrated I123-FP-CIT normal databases, account for population variability and ensure applicability across diverse patient demographics in neurological assessments?; Can the Gaussian filtering of PET data be customized by the user, and what is the documented impact of this filtering on SUV harmonization and overall quantitative accuracy in different clinical scenarios?; What are the performance benchmarks for visualizing 4D data across all layouts, and how does the 'Interactive Spectral Imaging' feature specifically improve diagnostic interpretation compared to previous multi-modality review methods?; How does the OpenApps framework facilitate the integration and performance of third-party applications like Cedars and Corridor 4DM within the MI Cardiology workflow, and what are the data exchange protocols?